Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Impact of rechallenge with imatinib in patients with advanced gastrointestinal stromal tumor after failure of imatinib and sunitinib.

Sawaki A, Kanda T, Komatsu Y, Nishida T.

Gastroenterol Res Pract. 2014;2014:342986. doi: 10.1155/2014/342986. Epub 2014 Jan 22.

PMID:
24587795
[PubMed]
Free PMC Article
2.

Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106).

Shirao K, Boku N, Yamada Y, Yamaguchi K, Doi T, Goto M, Nasu J, Denda T, Hamamoto Y, Takashima A, Fukuda H, Ohtsu A; Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2013 Oct;43(10):972-80. doi: 10.1093/jjco/hyt114. Epub 2013 Sep 7.

PMID:
24014884
[PubMed - indexed for MEDLINE]
Free Article
3.

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.

Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G, Kurteva G, Volovat C, Moiseyenko VM, Gorbunova V, Park JO, Sawaki A, Celik I, Götte H, Melezínková H, Moehler M; Arbeitsgemeinschaft Internistische Onkologie and EXPAND Investigators.

Lancet Oncol. 2013 May;14(6):490-9. doi: 10.1016/S1470-2045(13)70102-5. Epub 2013 Apr 15.

PMID:
23594786
[PubMed - indexed for MEDLINE]
4.

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.

Ito T, Okusaka T, Nishida T, Yamao K, Igarashi H, Morizane C, Kondo S, Mizuno N, Hara K, Sawaki A, Hashigaki S, Kimura N, Murakami M, Ohki E, Chao RC, Imamura M.

Invest New Drugs. 2013 Oct;31(5):1265-74. doi: 10.1007/s10637-012-9910-y. Epub 2012 Dec 27.

PMID:
23269537
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators.

Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22.

PMID:
23177515
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Efficacy of docetaxel in patients with paclitaxel-resistant advanced gastric cancer.

Kondoh C, Takahari D, Shitara K, Mizota A, Nomura M, Yokota T, Ura T, Ito S, Kawai H, Sawaki A, Muro K.

Gan To Kagaku Ryoho. 2012 Oct;39(10):1511-5.

PMID:
23064062
[PubMed - indexed for MEDLINE]
7.

Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.

Ogura T, Yamao K, Hara K, Mizuno N, Hijioka S, Imaoka H, Sawaki A, Niwa Y, Tajika M, Kondo S, Tanaka T, Shimizu Y, Bhatia V, Higuchi K, Hosoda W, Yatabe Y.

J Gastroenterol. 2013 May;48(5):640-6. doi: 10.1007/s00535-012-0664-2. Epub 2012 Sep 15.

PMID:
22983505
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.

Yamaguchi K, Sawaki A, Doi T, Satoh T, Yamada Y, Omuro Y, Nishina T, Boku N, Chin K, Hamamoto Y, Takiuchi H, Komatsu Y, Saji S, Koizumi W, Miyata Y, Sato A, Baba E, Tamura T, Abe T, Ohtsu A.

Gastric Cancer. 2013 Apr;16(2):175-82. doi: 10.1007/s10120-012-0167-0. Epub 2012 Jul 11. Erratum in: Gastric Cancer. 2013 Apr;16(2):183-4.

PMID:
22782463
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Efficacy of mosapride citrate with polyethylene glycol solution for colonoscopy preparation.

Tajika M, Niwa Y, Bhatia V, Kawai H, Kondo S, Sawaki A, Mizuno N, Hara K, Hijioka S, Matsumoto K, Kobayashi Y, Saeki A, Akabane A, Komori K, Yamao K.

World J Gastroenterol. 2012 May 28;18(20):2517-25. doi: 10.3748/wjg.v18.i20.2517.

PMID:
22654449
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer.

Shitara K, Sawaki A, Matsuo K, Kondo C, Takahari D, Ura T, Tajika M, Niwa Y, Muro K.

Int J Clin Oncol. 2013 Jun;18(3):539-46. doi: 10.1007/s10147-012-0416-6. Epub 2012 May 3.

PMID:
22552360
[PubMed - indexed for MEDLINE]
11.

Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.

Ogura T, Yamao K, Sawaki A, Mizuno N, Hara K, Hijioka S, Niwa Y, Tajika M, Kondo S, Shimizu Y, Bhatia V, Higuchi K, Hosoda W, Yatabe Y.

Gastrointest Endosc. 2012 Apr;75(4):769-74. doi: 10.1016/j.gie.2011.11.012. Epub 2012 Jan 28.

PMID:
22284089
[PubMed - indexed for MEDLINE]
12.

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study.

Sawaki A, Ohashi Y, Omuro Y, Satoh T, Hamamoto Y, Boku N, Miyata Y, Takiuchi H, Yamaguchi K, Sasaki Y, Nishina T, Satoh A, Baba E, Tamura T, Abe T, Hatake K, Ohtsu A.

Gastric Cancer. 2012 Jul;15(3):313-22. doi: 10.1007/s10120-011-0118-1. Epub 2011 Dec 17.

PMID:
22179434
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients.

Kanda T, Nishida T, Wada N, Kobayashi O, Yamamoto M, Sawaki A, Boku N, Koseki M, Doi T, Toh Y, Kakeji Y, Sugiyama T, Komatsu Y, Kikuchi S, Ogoshi K, Katai H, Miyachi K, Hirota S, Ohtsu A.

Int J Clin Oncol. 2013 Feb;18(1):38-45. doi: 10.1007/s10147-011-0339-7. Epub 2011 Nov 23.

PMID:
22105894
[PubMed - indexed for MEDLINE]
14.

[Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].

Ogura T, Tajika M, Niwa Y, Kawai H, Kondo S, Sawaki A, Mizuno N, Hara K, Hijioka S, Nakamura M, Higuchi K, Goto H, Yamao K.

Nihon Shokakibyo Gakkai Zasshi. 2011 Oct;108(10):1712-9. Review. Japanese.

PMID:
21971145
[PubMed - indexed for MEDLINE]
15.

Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population.

Ennishi D, Shitara K, Ito H, Hosono S, Watanabe M, Ito S, Sawaki A, Yatabe Y, Yamao K, Tajima K, Tanimoto M, Tanaka H, Hamajima N, Matsuo K.

Cancer Sci. 2011 Dec;102(12):2231-5. doi: 10.1111/j.1349-7006.2011.02062.x. Epub 2011 Sep 19.

PMID:
21854509
[PubMed - indexed for MEDLINE]
16.

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.

Ohtsu A, Shah MA, Van Cutsem E, Rha SY, Sawaki A, Park SR, Lim HY, Yamada Y, Wu J, Langer B, Starnawski M, Kang YK.

J Clin Oncol. 2011 Oct 20;29(30):3968-76. doi: 10.1200/JCO.2011.36.2236. Epub 2011 Aug 15.

PMID:
21844504
[PubMed - indexed for MEDLINE]
Free Article
17.

Contrast-enhanced endoscopic ultrasonography (CE-EUS) findings in adrenal metastasis from renal cell carcinoma.

Hijioka S, Sawaki A, Mizuno N, Hara K, Mekky MA, El-Amin H, El-Abdeen Ahmed Sayed Z, Tajika M, Niwa Y, Yamao K.

J Med Ultrason (2001). 2011 Apr;38(2):89-92. Epub 2011 Jan 5.

PMID:
21836820
[PubMed]
Free PMC Article
18.

Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.

Okamoto Y, Sawaki A, Ito S, Nishida T, Takahashi T, Toyota M, Suzuki H, Shinomura Y, Takeuchi I, Shinjo K, An B, Ito H, Yamao K, Fujii M, Murakami H, Osada H, Kataoka H, Joh T, Sekido Y, Kondo Y.

Gut. 2012 Mar;61(3):392-401. doi: 10.1136/gut.2011.241034. Epub 2011 Jun 27.

PMID:
21708825
[PubMed - indexed for MEDLINE]
19.

ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection.

Nakao M, Matsuo K, Ito H, Shitara K, Hosono S, Watanabe M, Ito S, Sawaki A, Iida S, Sato S, Yatabe Y, Yamao K, Ueda R, Tajima K, Hamajima N, Tanaka H.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1665-72. doi: 10.1158/1055-9965.EPI-11-0213. Epub 2011 Jun 15.

PMID:
21680535
[PubMed - indexed for MEDLINE]
Free Article
20.

[Metastasis of uterine leiomyosarcoma to the pancreas--usefulness and limitations of EUS-FNA].

Ogura T, Yamao K, Hijioka S, Hara K, Sawaki A, Mizuno N, Niwa Y, Tajika M, Kawai H, Kondo S, Saeki A, Akabane A, Haba S, Tomono T, Shimizu S, Shimizu Y, Hosoda K, Yatabe Y.

Nihon Shokakibyo Gakkai Zasshi. 2011 Jun;108(6):987-96. Japanese.

PMID:
21646767
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk